- Home
- Publications
- Publication Search
- Publication Details
Title
Apremilast: First Global Approval
Authors
Keywords
Atopic Dermatitis, Psoriatic Arthritis, Plaque Psoriasis, Bath Ankylose Spondylitis Disease Activity Index, Dermatology Life Quality Index
Journal
DRUGS
Volume 74, Issue 7, Pages 825-837
Publisher
Springer Nature
Online
2014-05-05
DOI
10.1007/s40265-014-0218-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
- (2014) C. Birbara et al. ANNALS OF THE RHEUMATIC DISEASES
- SAT0280 Efficacy of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis, Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial
- (2014) C. Birbara et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
- (2014) Philip J. Mease et al. DRUGS
- Therapeutic Strategies in Psoriasis Patients with Psoriatic Arthritis: Focus on New Agents
- (2013) Emily Yiping Gan et al. BIODRUGS
- Phosphodiesterase 4-targeted treatments for autoimmune diseases
- (2013) Neal Kumar et al. BMC Medicine
- Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
- (2013) Vibeke Strand et al. Health and Quality of Life Outcomes
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis
- (2012) Ejaz Pathan et al. ANNALS OF THE RHEUMATIC DISEASES
- A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
- (2012) Aman Samrao et al. ARCHIVES OF DERMATOLOGY
- Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
- (2012) Peter Schafer BIOCHEMICAL PHARMACOLOGY
- An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: A case series
- (2012) Joan Paul et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study
- (2012) K.A. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
- (2012) Kim Papp et al. LANCET
- Apremilast in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Study
- (2012) Gregory P. McLENNAN et al. LUTS-Lower Urinary Tract Symptoms
- Efficacy and Safety of Apremilast in Chronic Cutaneous Sarcoidosis
- (2011) Robert P. Baughman ARCHIVES OF DERMATOLOGY
- The Cornified Envelope: A First Line of Defense against Reactive Oxygen Species
- (2011) Matthias Schäfer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Disposition, metabolism and mass balance of [14C]apremilast following oral administration
- (2011) Matthew Hoffmann et al. XENOBIOTICA
- Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis
- (2010) Fiona E McCann et al. ARTHRITIS RESEARCH & THERAPY
- Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
- (2009) PH Schafer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast
- (2008) A. B. Gottlieb et al. CURRENT MEDICAL RESEARCH AND OPINION
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alice Gottlieb et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search